Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04618146
Other study ID # 680-9\2020
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date November 10, 2020
Est. completion date March 2021

Study information

Verified date February 2021
Source Minia University
Contact Sohair A Megalla, MD
Phone +20 120 003 6447
Email Sohair.Adeeb@minia.edu.eg
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is designed to see the effect of low dose intrathecal morphine on promting enhanced recovery after cesarean delivery with early ambulation and reduction of hospital stay.


Description:

Parturients showing for elective cesarean section will be randomized into 3 groups by a computer generated randomization list. Each randomization slip will be put in a sealed envelope until patient enrollment. Patients will be divided into Group C: control group, given intrathecal bupivacaine 12.5 mg. Group M25: intrathecal bupivacaine 12.5mg + morphine 25 microgram. Group M50: intrathecal bupivacaine 12.5mg + morphine 50 microgram.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date March 2021
Est. primary completion date March 2021
Accepts healthy volunteers No
Gender Female
Age group 16 Years to 45 Years
Eligibility Inclusion Criteria: - Females scheduled for cesarean section - Age: 16-45 yrs. - Gestation age >38 weeks. - ASA I,II Exclusion Criteria: - Refusal to participate. - Significant cardiac, hepatic or renal dysfunction. - History of chronic itching problem, or hyperemesis during pregnancy

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Morphine Sulfate
intrathecal low dose morphine for early return to normal activity without opioid related complications.
Bupivacaine Hydrochloride
intrathecal bupivacaine 0.5%

Locations

Country Name City State
Egypt Minia university Minya

Sponsors (1)

Lead Sponsor Collaborator
Minia University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pain postoperative postoperative pain using Numerical pain score 0 no pain - 10 severe intolerable pain 2 hours postoperatively
Primary Pain postoperative postoperative pain using Numerical pain score 0 no pain - 10 severe intolerable pain 4 hours postoperatively
Primary Pain postoperative postoperative pain using Numerical pain score 0 no pain - 10 severe intolerable pain 24 hours postoperatively
Secondary vomiting four-point rating score (1: no nausea or vomiting, 2: queasy, 3: severe nausea, 4: vomiting). 2 hours postoperative
Secondary vomiting four-point rating score (1: no nausea or vomiting, 2: queasy, 3: severe nausea, 4: vomiting). 4 hours postoperative
Secondary vomiting four-point rating score (1: no nausea or vomiting, 2: queasy, 3: severe nausea, 4: vomiting). 24 hours postoperative
Secondary itching four-point rating score (1: no itching, 2: mild,face, no traetment needed 3: severe itching, allover the body). 2 hours postoperative
Secondary itching four-point rating score (1: no itching, 2: mild,face, no traetment needed 3: severe itching, allover the body). 4 hours postoperative
Secondary itching four-point rating score (1: no itching, 2: mild,face, no traetment needed 3: severe itching, allover the body). 24 hours postoperative
Secondary respiratory depression respiratory rate less than 8 breaths \ minute 4 hours postoperative
See also
  Status Clinical Trial Phase
Completed NCT05480111 - The Role of Quadratus Lumborum Blocks Following Minimally Invasive Hysterectomy Phase 4
Completed NCT06129305 - Erector Spina Muscle Distance From the Skin at Different Thoracal Elevations
Completed NCT04401826 - Micro-surgical Treatment of Gummy Smile N/A
Recruiting NCT04020133 - the Role of Popliteal Plexus Block in Pain Management After Anterior Cruciate Ligament Reconstruction. N/A
Completed NCT03023462 - Efficacy of an Anterior Quadratus Lumborum Block vs. a TAP-block for Inguinal Hernia Repair N/A
Completed NCT03652103 - Efficiency of Erector Spinae Plane Block For Patients Undergoing Percutaneous Nephrolithotomy Phase 4
Completed NCT03546738 - Spinal Cord Burst Stimulation for Chronic Radicular Pain Following Lumbar Spine Surgery N/A
Withdrawn NCT03528343 - Narcotic vs. Non-narcotic Pain Regimens After Pediatric Appendectomy Phase 1/Phase 2
Terminated NCT03261193 - ITM + Bupivacaine QLB vs. ITM + Sham Saline QLB for Cesarean Delivery Pain Phase 3
Completed NCT02525133 - Phase 3 Study of Efficacy and Safety of the XaraColl® Bupivacaine Implant After Hernioplasty Phase 3
Completed NCT03244540 - Regional Analgesia After Cesarean Section Phase 4
Enrolling by invitation NCT05316168 - Post Operative Pain Management for ACL Reconstruction Phase 3
Recruiting NCT04130464 - Intraperitoneal Infusion of Analgesic for Postoperative Pain Management Phase 4
Enrolling by invitation NCT04574791 - Addition of Muscle Relaxants in a Multimodal Analgesic Regimen for Analgesia After Primary Total Knee Arthroplasty N/A
Completed NCT04526236 - Influence of Aging on Perioperative Methadone Dosing Phase 4
Completed NCT04073069 - Scalp Infiltration With Diprospan Plus Ropivacaine for Postoperative Pain After Craniotomy in Adults Phase 4
Recruiting NCT05351229 - Intrathecal Morphine for Analgesia in Video-assisted Thoracic Surgery Phase 4
Enrolling by invitation NCT05543109 - Ultrasound Guided Psoas Compartment Block vs Suprainguinal Fascia Iliaca Compartment Block N/A
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Completed NCT04919317 - Combination Dexamethasone and Bupivacaine Pain Control in Reduction Mammaplasty Phase 2